Individualized Fortification of Human Milk for Infants Born ≤ 1250 g (MaxiMoM-InForM)
Launched by THE HOSPITAL FOR SICK CHILDREN · Mar 31, 2022
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
The MaxiMoM-InForM study is looking at how to provide the best nutrition for very low birth weight infants, specifically those born weighing 1250 grams or less. These babies have special nutritional needs, and while extra nutrients are usually added to their human milk feeds, many still struggle with growth and development after leaving the hospital. This trial will compare three different methods of fortifying human milk—one standard method and two individualized approaches—to see which one better supports the babies' growth and health during their hospital stay.
To participate in this study, infants must weigh 1250 grams or less at birth, and caregivers need to give consent for their participation. The study will randomly assign babies to receive milk fortified in one of the three methods until they reach 36 weeks of age or are discharged from the hospital. Throughout the trial, researchers will monitor the babies' growth and health, and later assess their development when they are 18 to 24 months old. This research aims to find the most effective way to support these vulnerable infants and their families.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ≤1250 g birth weight or Gestational Age \<30+0 weeks and \<1500 g birth weight.
- • Parental/guardian consent to participate.
- • Consent for the use of pasteurized donor milk if mother's milk is not available.
- Exclusion Criteria:
- • Infant received fortifier or formula before Study Day 1.
- • Study Day 1 to occur after postnatal day 21.
- • Infants with congenital or chromosomal anomalies or brain injury that may affect growth or neurodevelopment.
- • Enrollment in any other clinical study affecting nutritional management during the feeding intervention.
- • Reasonable potential that the infant will be transferred to a NICU where the study protocol will not be continued before they have completed at least 4 weeks of the feeding intervention.
About The Hospital For Sick Children
The Hospital for Sick Children (SickKids) is a leading pediatric health care and research institution located in Toronto, Canada. With a commitment to advancing child health through innovative research, education, and clinical care, SickKids is recognized globally for its expertise in pediatric medicine. The hospital actively sponsors clinical trials aimed at improving treatment outcomes and enhancing the quality of life for children with various health conditions. By fostering collaboration among multidisciplinary teams and leveraging state-of-the-art facilities, SickKids strives to translate research findings into tangible advancements in pediatric care, ensuring that children receive the best possible treatments based on the latest scientific evidence.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Newmarket, Ontario, Canada
Toronto, Ontario, Canada
Toronto, Ontario, Canada
Toronto, Ontario, Canada
Toronto, Ontario, Canada
North York, Ontario, Canada
Richmond Hill, Ontario, Canada
Edmonton, Alberta, Canada
Oshawa, Ontario, Canada
Markham, Ontario, Canada
Brampton, Ontario, Canada
Mississauga, Ontario, Canada
North York, Ontario, Canada
Etobicoke, Ontario, Canada
Mississauga, Ontario, Canada
Scarborough, Ontario, Canada
Scarborough, Ontario, Canada
Toronto, Ontario, Canada
Toronto, Ontario, Canada
Toronto, Ontario, Canada
Patients applied
Trial Officials
Deborah O'Connor, PhD RD
Principal Investigator
The Hospital for Sick Children
Sharon Unger, MD
Principal Investigator
Sinai Health System
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials